Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study

Detalhes bibliográficos
Autor(a) principal: Tuylu, Tugba
Data de Publicação: 2014
Outros Autores: Sari, Ismail, Solmaz, Dilek, Kozaci, Didem Leyla, Akar, Servet, Gunay, Necati, Onen, Fatos, Akkoc, Nurullah
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/96927
Resumo: OBJECTIVES: New bone formation is one of the hallmark characteristics of ankylosing spondylitis, which is thereby associated with syndesmophytes. Fetuin-A is a molecule that is abundantly found in calcified tissues and it shows high affinity for calcium phosphate minerals and related compounds. Considering the role of fetuin-A in the regulation of calcified matrix metabolism, we compared the fetuin-A levels in ankylosing spondylitis patients with syndesmophytes with those in patients without syndesmophytes and in healthy controls. We also studied other biomarkers that are thought to be related to syndesmophytes. METHODS: Ninety-four patients (49 patients without syndesmophytes, 67.3% male, 40.7±8.7 years; 45 patients with syndesmophytes, 71.1% M, 43.9±9.9 years) and 68 healthy controls (44.2±10.6 years and 70.6% male) were included in this study. Syndesmophytes were assessed on the lateral radiographs of the cervical and lumbar spine. The serum levels of fetuin-A, dickkopf-1, sclerostin, IL-6, high-sensitivity C-reactive protein and bone morphogenetic protein-7 were measured with an enzyme-linked immunosorbent assay. RESULTS: Patients with syndesmophytes had significantly higher levels of fetuin-A compared with patients without syndesmophytes and controls (1.16±0.13, 1.05±0.09 and 1.08±0.13 mg/ml, respectively). However, fetuin-A was not different between the patients without syndesmophytes and controls. Bone morphogenetic protein-7 was significantly lower; dickkopf-1 was significantly higher in patients with ankylosing spondylitis compared with controls. The sclerostin concentrations were not different between the groups. In regression analysis, fetuin-A was an independent, significant predictor of syndesmophytes. CONCLUSION: Our results suggest that fetuin-A may a role in the pathogenesis of bony proliferation in ankylosing spondylitis.
id USP-19_70b9655ae555f881bdd9c66532e254f0
oai_identifier_str oai:revistas.usp.br:article/96927
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study OBJECTIVES: New bone formation is one of the hallmark characteristics of ankylosing spondylitis, which is thereby associated with syndesmophytes. Fetuin-A is a molecule that is abundantly found in calcified tissues and it shows high affinity for calcium phosphate minerals and related compounds. Considering the role of fetuin-A in the regulation of calcified matrix metabolism, we compared the fetuin-A levels in ankylosing spondylitis patients with syndesmophytes with those in patients without syndesmophytes and in healthy controls. We also studied other biomarkers that are thought to be related to syndesmophytes. METHODS: Ninety-four patients (49 patients without syndesmophytes, 67.3% male, 40.7±8.7 years; 45 patients with syndesmophytes, 71.1% M, 43.9±9.9 years) and 68 healthy controls (44.2±10.6 years and 70.6% male) were included in this study. Syndesmophytes were assessed on the lateral radiographs of the cervical and lumbar spine. The serum levels of fetuin-A, dickkopf-1, sclerostin, IL-6, high-sensitivity C-reactive protein and bone morphogenetic protein-7 were measured with an enzyme-linked immunosorbent assay. RESULTS: Patients with syndesmophytes had significantly higher levels of fetuin-A compared with patients without syndesmophytes and controls (1.16±0.13, 1.05±0.09 and 1.08±0.13 mg/ml, respectively). However, fetuin-A was not different between the patients without syndesmophytes and controls. Bone morphogenetic protein-7 was significantly lower; dickkopf-1 was significantly higher in patients with ankylosing spondylitis compared with controls. The sclerostin concentrations were not different between the groups. In regression analysis, fetuin-A was an independent, significant predictor of syndesmophytes. CONCLUSION: Our results suggest that fetuin-A may a role in the pathogenesis of bony proliferation in ankylosing spondylitis. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2014-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/9692710.6061/clinics/2014(10)07Clinics; Vol. 69 No. 10 (2014); 688-693Clinics; v. 69 n. 10 (2014); 688-693Clinics; Vol. 69 Núm. 10 (2014); 688-6931980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/96927/96007Copyright (c) 2015 Clinicsinfo:eu-repo/semantics/openAccessTuylu, Tugba Sari, Ismail Solmaz, Dilek Kozaci, Didem Leyla Akar, Servet Gunay, Necati Onen, Fatos Akkoc, Nurullah 2015-03-27T17:35:39Zoai:revistas.usp.br:article/96927Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2015-03-27T17:35:39Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study
title Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study
spellingShingle Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study
Tuylu, Tugba
title_short Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study
title_full Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study
title_fullStr Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study
title_full_unstemmed Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study
title_sort Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study
author Tuylu, Tugba
author_facet Tuylu, Tugba
Sari, Ismail
Solmaz, Dilek
Kozaci, Didem Leyla
Akar, Servet
Gunay, Necati
Onen, Fatos
Akkoc, Nurullah
author_role author
author2 Sari, Ismail
Solmaz, Dilek
Kozaci, Didem Leyla
Akar, Servet
Gunay, Necati
Onen, Fatos
Akkoc, Nurullah
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Tuylu, Tugba
Sari, Ismail
Solmaz, Dilek
Kozaci, Didem Leyla
Akar, Servet
Gunay, Necati
Onen, Fatos
Akkoc, Nurullah
description OBJECTIVES: New bone formation is one of the hallmark characteristics of ankylosing spondylitis, which is thereby associated with syndesmophytes. Fetuin-A is a molecule that is abundantly found in calcified tissues and it shows high affinity for calcium phosphate minerals and related compounds. Considering the role of fetuin-A in the regulation of calcified matrix metabolism, we compared the fetuin-A levels in ankylosing spondylitis patients with syndesmophytes with those in patients without syndesmophytes and in healthy controls. We also studied other biomarkers that are thought to be related to syndesmophytes. METHODS: Ninety-four patients (49 patients without syndesmophytes, 67.3% male, 40.7±8.7 years; 45 patients with syndesmophytes, 71.1% M, 43.9±9.9 years) and 68 healthy controls (44.2±10.6 years and 70.6% male) were included in this study. Syndesmophytes were assessed on the lateral radiographs of the cervical and lumbar spine. The serum levels of fetuin-A, dickkopf-1, sclerostin, IL-6, high-sensitivity C-reactive protein and bone morphogenetic protein-7 were measured with an enzyme-linked immunosorbent assay. RESULTS: Patients with syndesmophytes had significantly higher levels of fetuin-A compared with patients without syndesmophytes and controls (1.16±0.13, 1.05±0.09 and 1.08±0.13 mg/ml, respectively). However, fetuin-A was not different between the patients without syndesmophytes and controls. Bone morphogenetic protein-7 was significantly lower; dickkopf-1 was significantly higher in patients with ankylosing spondylitis compared with controls. The sclerostin concentrations were not different between the groups. In regression analysis, fetuin-A was an independent, significant predictor of syndesmophytes. CONCLUSION: Our results suggest that fetuin-A may a role in the pathogenesis of bony proliferation in ankylosing spondylitis.
publishDate 2014
dc.date.none.fl_str_mv 2014-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/96927
10.6061/clinics/2014(10)07
url https://www.revistas.usp.br/clinics/article/view/96927
identifier_str_mv 10.6061/clinics/2014(10)07
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/96927/96007
dc.rights.driver.fl_str_mv Copyright (c) 2015 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2015 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 69 No. 10 (2014); 688-693
Clinics; v. 69 n. 10 (2014); 688-693
Clinics; Vol. 69 Núm. 10 (2014); 688-693
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222761670410240